Based on the Applied DNA Sciences Inc stock forecast from 0 analysts, the average analyst target price for Applied DNA Sciences Inc is not available over the next 12 months. Applied DNA Sciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Applied DNA Sciences Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Applied DNA Sciences Inc’s stock price was USD 0.81. Applied DNA Sciences Inc’s stock price has changed by -11.58% over the past week, -54.75% over the past month and -99.76% over the last year.
No recent analyst target price found for Applied DNA Sciences Inc
No recent average analyst rating found for Applied DNA Sciences Inc
Company Overview Applied DNA Sciences Inc
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York. Read Less
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing...Read More
Frequently Asked Questions About Applied DNA Sciences Inc (APDN) Stock
Stock Target Advisor's fundamental analysis for Applied DNA Sciences Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on APDN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on APDN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on APDN's stock to indicate if its overvalued.
The last closing price of APDN's stock was USD 0.81.
The most recent market capitalization for APDN is USD 2.14M.
Unfortunately we do not have enough analyst data on APDN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Applied DNA Sciences Inc's stock.
As per our most recent records Applied DNA Sciences Inc has 46 Employees.
Applied DNA Sciences Inc's registered address is 50 Health Sciences Drive, Stony Brook, NY, United States, 11790.
You can get more information about it from Applied DNA Sciences Inc's website at https://www.adnas.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Applied DNA Sciences Inc (APDN) Stock
Stock Target Advisor's fundamental analysis for Applied DNA Sciences Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on APDN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on APDN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on APDN's stock to indicate if its overvalued.
The last closing price of APDN's stock was USD 0.81.
The most recent market capitalization for APDN is USD 2.14M.
Unfortunately we do not have enough analyst data on APDN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Applied DNA Sciences Inc's stock.
As per our most recent records Applied DNA Sciences Inc has 46 Employees.
Applied DNA Sciences Inc's registered address is 50 Health Sciences Drive, Stony Brook, NY, United States, 11790.
You can get more information about it from Applied DNA Sciences Inc's website at https://www.adnas.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for APDN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
